International Hormesis Society - 2007 Conference Overview

2007 Conference Overview

Title and Site for International Hormesis Society’s 2007 Annual Conference May 1 – 2, 2007	HORMESIS 2007: IMPLICATIONS FOR TOXICOLOGY, MEDICINE, AND RISK ASSESSMENT University of Massachusetts, Amherst, MA US
Conference Coordinator	Denise Leonard, MSc
Registration Fees	Full Two Days: $399 Full Two Days for International Hormesis Society Members: $299 Government and Academic Rate: $199 Government and Academic Rate for International Hormesis Society Members: $149 Student Rate: $99 Student Rate for International Hormesis Society Members: $74
Award Recipient for “Outstanding Career Achievement in the Field of Hormesis”	Edouard Alexandre Azzam, PhD; Ronald E. J. Mitchel, PhD; Erno Tyihak, PhD Bios available at the “Awards” link on the Society website
Award Recipient for “Outstanding New Investigator in the Field of Hormesis”	Nina Cedergreen, PhD Bio available at the “Awards” link on the Society website
Award Recipient for “Outstanding Leadership in the Field of Hormesis”	Sadao Hattori, PhD Bio available at the “Awards” link on the Society website
Platform Presentation: Plenary	Moderator: A. Wallace Hayes, Harvard School of Public Health, Cambridge, MA Mechanisms of Action and Therapeutic Potential of Neurohormetic Phytochemicals Mark Mattson, National Institute on Aging Intramural Research Program, Baltimore, MD Homeostasis:The Yin and Yang of Autoimmunity Michal Schwartz, The Weizmann Institute of Science, Rehovot, Israel How Low is Low Enough? Role of Science, Policy and Public Opinion Roger O. McClellan, Advisor, Toxicology and Human Health Risk Analysis, Albuquerque, MN
Platform Presentation: Toxicology	Moderator: George Hoffmann, Holy Cross College,Worcester, MA Activation of Adaptive Cellular Networks and Hormetic Dose-Response Relationships Mel Andersen, Harvey J. Clewell, CIIT Centers for HealthResearch, Research Triangle Park, NC Annie M. Jarabek, National Health and Environmental Effects Research Laboratory, US EPA, Research Triangle Park, NC Qiang Zhang, Jingbo Pi, CIIT Centers for Health Research, Research Triangle Park, NC Hormesis with Drug-induced Cytotoxicity Peter J O’Brien, University College Dublin, Belfield, Dublin 4, Ireland Non-Monotonic Dose-Toxicity Effects and Behavioral Function: Low-Dose Impairments from Developmental Pesticide Exposure Edward D. Levin, Ph.D., Duke University Medical Center, Durham, NC Hormesis with Herbicides: Glyphosate as a Case Study Stephen O. Duke, Joanna Bajsa, Scott R. Baerson, USDA, ARS, Natural Products Utilization Research, University, MS Nina Cedergreen, University of Copenhangen, Tåstrup, Denmark Edivaldo D. Velini, University of São Paulo State, Botucatu, Brazil Biological Properties in Genes for Low-Dose Regulation of the Embryonic Transcriptome Thomas B. Knudsen, Amar V. Sing, University of Louisville, Louisville, KY
Platform Presentation: Biomedical	Moderator: Paolo F. Ricci, University of Massachusetts, Amherst, MA Mechanisms Underlying the Bell-shaped Response of Neurons to Glutamate Giles Hardingham, University of Edinburgh, Edinburgh, Scotland Biphasic Action of Steroids on Neural Function: Mechanistic and Therapeutic Implications Roberta Brinton, University of Southern California, Los Angeles, CA Genes and Small Molecules that Extend Lifespan: Evidence for Xenohormesis David Sinclair, Harvard Medical School, Boston, MA Hormesis: Dermatologic Opportunities and Options Howard Maibach, University of California, San Francisco, CA Experimental and Clinical Information for the Possible Application of LDR-induced Hormesis and Adaptive Response in Medical Practice Lu Cai, The University of Louisville, Louisville, KY
Platform Presentation: Multiple Stressors and Hormesis	Moderators: Carmel Mothersill, McMaster University, Hamilton, Ontario, Canada William A. Bernhard, University of Rochester Medical Center, Rochester,NY Which DNA Damage is likely to be Relevant in Hormetic Responses? Shubhadeep Purkayastha, University of Rochester Medical Center, Rochester, NY Jamie R. Milligan, University of California at San Diego, La Jolla, CA William A. Bernhard, University of Rochester Medical Center, Rochester, NY Interactions Between Chemicals and Radiation - 2+2 May Not Equal 4 John D. Zimbrick, Dmytro Grygoryev, Oleksandr Moskalenko, Colorado State University, Fort Collins, CO Biological Mechanisms of Radiation/Chemical Interactions Which Could Lead to Hormetic Radioprotective Effects Carmel Mothersill, McMaster University, Hamilton, Ontario, Canada Hormesis in Joint Action Studies with Phytotoxins from Parthenium hysterophorus L. Regina G. Belz, University of Hohenheim, Stuttgart, Germany Targeted Radiotherapy: Microgray Doses and the Bystander Effect Robert J. Mairs, Marie Boyd, Glasgow University, UK Beatson Laboratories, Glasgow, Scotland Michael R. Zalutsky, Duke University Medical Centre, Durham, NC Natasha E. Fullerton, Crusade Laboratories Ltd, Glasgow, Scotland Ethical and Philosophical Aspects of Dose-Response Models Deborah Oughton, Norwegian University of Life Sciences, Aas, Norway Hormetic Effects and Legal Difficulties Colin Seymour, Carmel Mothersill, McMaster University, Hamilton, Ontario, Canada
Platform Presentation: Radiation	Moderators: Bobby Scott, LRRI, Albuquerque, NM, Edouard Azzam, New Jersey Medical School, Newark, NJ Mechanisms Underlying the Expression of Low-Dose gamma-Ray-Induced Adaptive Responses in Human and Rodent Fibroblasts Edouard Azzam, New Jersey Medical School, Newark, NJ Evidence for Radiation Hormesis in Human Lymphocytes Kanokporn Noy Rithidech, Stony Brook University, Stony Brook, NY Bobby R. Scott, Lovelace Respiratory Research Institute, Albuquerque, NM Conferral of Immunity to Cancer and Other Diseases by Continuous Low-Dose Radiation Brenda Laster, Ilana Nathan, Jacob Gopas, Ben Gurion University, Beer Sheva, Israel John Kalef-Ezra, University of Ioannina Medical School, Ioannina, Greece Low Doses, Cross Adaptation and Multiple Stressors Ron Mitchel, Marilyne Audette-Stuart, Tamara Yankovich, Atomic Energy of Canada Limited, Chalk River, ON, Canada Exploring the Mechanisms of the Radioadaptive Response at Chernobyl Brenda Rodgers, Texas Tech University, Lubbock, TX, Jeffery K. Wickliffe, University of Texas Medical Branch, Galveston, TX, Kristen M. Holmes, M.D. Anderson Cancer Center, Houston, TX, Adam D. Brown, The University of Texas Health Science Center, San Antonio, TX Robert. J. Baker, Texas Tech University, Biological Sciences, Lubbock, TX Ronald K. Chesser, Texas Tech University, Lubbock, TX Recent Biological Results against the Validity of the LNT Hypothesis Dietrich Averbeck, Didier Boucher, Institut Curie-Section de Recherche, Orsay Cedex, France It’s Time for a New Low-dose Radiation Risk Assessment Paradigm—One that Acknowledges Hormesis Bobby R. Scott, Lovelace Respiratory Research Institute, Albuquerque, NM